The most outstanding characteristic of MHC class II molecules is their extensive polymorphism. This polymorphism allows a population to ensure its survival by maximizing the possibility of generating antigenic peptides derived from infectious agents or dysfunctional cells. The structure of the class II MHC protein is characterized by the presence of a peptide-binding groove running the length of the molecule. Polymorphic amino acid residues are associated predominantly with the groove, suggesting heavy selection for variability in this part of the protein. The current view of the interaction of MHC class II and antigenic peptide is based on binding pockets in the MHC which accept side chains of amino acid """"""""anchor"""""""" residues on the peptide. All the identified pockets are polymorphic. The investigator will test the hypothesis that rules for peptide binding to any MHC class II molecule can be defined by examining each point of interaction in isolation and in combination. The examination will utilize a """"""""reversion"""""""" approach, in which a structural feature changed by a polymorphism leads to loss of function. The physico-chemical nature of the interaction can then be understood if function can be regained by a compensating change in the peptide. The investigator will start by making amino acid substitutions within the pockets of the MHC molecule and work outward, in order to determine whether peptide binding is merely a sum of the anchor residue contributions, or whether this interaction is more complex. The same rules will be applied to other interactions between class II MHC and accessories to antigen presentation, specifically the class II-associated invariant chain (Ii) and HLA-DM. The results obtained are expected to provide a clearer understanding of the interactions of peptide with all the different class II alleles, which would be beneficial for vaccine generation and peptide antagonist design.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI026085-11
Application #
6124199
Study Section
Special Emphasis Panel (ZRG2-EI (01))
Program Officer
Prasad, Shiv A
Project Start
1988-04-01
Project End
2002-11-30
Budget Start
1999-12-01
Budget End
2000-11-30
Support Year
11
Fiscal Year
2000
Total Cost
$253,263
Indirect Cost
Name
Bloodcenter of Wisconsin, Inc.
Department
Type
DUNS #
City
Milwaukee
State
WI
Country
United States
Zip Code
53233
Yassai, Maryam; Cooley, Brian; Gorski, Jack (2012) Developmental dynamics of post-selection thymic DN iNKT. PLoS One 7:e43509
Anderson, Matthew W; Gorski, Jack (2005) Cooperativity during the formation of peptide/MHC class II complexes. Biochemistry 44:5617-24
Hughes, Maureen M; Yassai, Maryam; Sedy, John R et al. (2003) T cell receptor CDR3 loop length repertoire is determined primarily by features of the V(D)J recombination reaction. Eur J Immunol 33:1568-75
Anderson, Matthew W; Gorski, Jack (2003) Cutting edge: TCR contacts as anchors: effects on affinity and HLA-DM stability. J Immunol 171:5683-7
Yassai, Maryam; Ammon, Kristin; Goverman, Joan et al. (2002) A molecular marker for thymocyte-positive selection: selection of CD4 single-positive thymocytes with shorter TCRB CDR3 during T cell development. J Immunol 168:3801-7
Yassai, Maryam; Afsari, Amin; Garlie, Jason et al. (2002) C-terminal anchoring of a peptide to class II MHC via the P10 residue is compatible with a peptide bulge. J Immunol 168:1281-5
De Palma, R; Wu, S; Sallusto, F et al. (1999) Use of antagonist peptides to inhibit in vitro T cell responses to Par j1, the major allergen of Parietaria judaica pollen. J Immunol 162:1982-7
Wu, S; Gorski, J (1997) Polymorphism at beta 85 and not beta 86 of HLA-DR1 is predominantly responsible for restricting the nature of the anchor side chain: implication for concerted effects of class II MHC polymorphism. Int Immunol 9:1495-502
Wu, S; Gorski, J (1996) The MHC class II-associated invariant chain-derived peptide clip binds to the peptide-binding groove of class II molecules. Mol Immunol 33:371-7
Wu, S; Gorski, J; Eckels, D D et al. (1996) T cell recognition of MHC class II-associated peptides is independent of peptide affinity for MHC and sodium dodecyl sulfate stability of the peptide/MHC complex. Effects of conservative amino acid substitutions at anchor position 1 of influenza matrix pr J Immunol 156:3815-20

Showing the most recent 10 out of 23 publications